Intensive glucose control offers no benefit after kidney transplant

11/5/2012 | Modern Medicine

Researchers found statistically similar rates of delayed graft function following kidney transplant in diabetes patients receiving intensive glucose control and a control group. The study in the Journal of Clinical Endocrinology & Metabolism also found an blood glucose target of less than 180 mg/dL was associated with a lower risk of organ rejection than targets of 70-110 mg/dL, suggesting tight glycemic control may offer no help immediately after the procedure.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations